| Member | Buys | Sells | Est. net | Last move |
|---|---|---|---|---|
| James French Hill AR02 | 1 | −$32.5K | Sold Dec 31, 25 | |
| Julie Johnson TX32 | 1 | −$8.0K | Sold Jan 15, 25 |
| Traded | Member | Owner | Type | Amount | Filed | Report |
|---|---|---|---|---|---|---|
| Dec 31, 25 | James French Hill AR02 | Self | Sell | $15,001 - $50,000 | Jan 23, 26 (23d) | |
| Jan 15, 25 | Julie Johnson TX32 | Joint | Sell | $1,001 - $15,000 | Feb 12, 25 (28d) |
From the House's STOCK Act reports (Senate not included). Members disclose trades, not holdings, as value ranges up to 45 days later, so amounts are estimates and “last move” is a hint at who still holds it, not a position. All recent congress trades
| Date | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Aug 31, 2026 | Hanson Bryan CraigChief Executive Officer | — | 67.3K | — |
| May 12, 2026 | Harrington Paul SOfficer | — | 4K | — |
| May 12, 2026 | Mcmillan Wayde DChief Financial Officer | — | 9.5K | — |
| May 12, 2026 | Hanson Bryan CraigChief Executive Officer | — | 34.3K | — |
| May 12, 2026 | Kirberger Marcela A.Officer | — | 4.5K | — |
| May 12, 2026 | Gomez Tammy LOfficer | — | 4K | — |
| May 12, 2026 | Landucci AmyChief Technology Officer | — | 4.4K | — |
| May 12, 2026 | Wilcox Mary TOfficer | — | 2.4K | — |
| Apr 29, 2026 | Wendell Amy McbrideDirector | — | 3.4K | — |
| Apr 29, 2026 | Weiland John HDirector | — | 3.4K | — |
| Apr 29, 2026 | Cox Carrie SmithDirector | — | 4.9K | — |
| Apr 29, 2026 | May Karen JDirector | — | 3.4K | — |
| Apr 29, 2026 | Eisenberg Glenn ADirector | — | 3.4K | — |
| Apr 29, 2026 | Harris Bernard A JrDirector | — | 3.4K | — |
| Apr 29, 2026 | Alban CarlosDirector | — | 3.4K | — |
| Apr 29, 2026 | Devore Susan DDirector | — | 3.4K | — |
| Apr 29, 2026 | Wilson Darryl LDirector | — | 3.4K | — |
| Apr 29, 2026 | Mily ElizabethDirector | — | 3.4K | — |
| Apr 29, 2026 | Edwards Shirley AnnDirector | — | 3.4K | — |
| Mar 26, 2026 | Weiland John HDirector | — | 2K | — |
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Year |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -2.9 | -3.6 | -12.0 | 3.2 | 11.3 | 2.9 | 10.7 | 6.6 | -3.2 | -3.2 | +7.7% | ||
| 2025 | 12.1 | 7.7 | -4.7 | -13.0 | 10.5 | 3.8 | -5.9 | 2.4 | -0.1 | -5.4 | 23.5 | -7.1 | +20.0% |
| 2024 | -6.5 | -8.7 | -10.9 | 11.3 | 8.9 | 8.8 | 4.1 | -1.5 | -7.6 | −5.0% |
Solventum Corporation, a healthcare company, develops, manufactures, and commercializes a portfolio of solutions to address critical customer and patient needs in the United States and internationally. It operates through three segments: Medsurg, Dental Solutions, and Health Information Systems. The Medsurg segment offers solutions, such as negative pressure wound therapy, advanced wound dressings, advanced skin care, synthetic tissue matrices, I.V. site management, sterilization assurance, temperature management, surgical supplies, medical tapes and wraps, stethoscopes, medical electrodes, and medical technologies for original equipment manufacturers. The Dental Solutions segment provides dental and orthodontic products, including brackets, aligners, restorative cements, and bonding agents to span the life of the tooth, and products for preventative dental care, direct and indirect restoration, and orthodontic needs. The Health Information Systems segment offers healthcare systems with software solutions comprising computer-assisted physician documentation, direct-to-bill and coding automation, classification methodologies, speech recognition, and data visualization platforms. The company sells its products and services through direct-to-consumer, distribution, key account management, inside sales, and e-commerce. Solventum Corporation was incorporated in 2023 and is headquartered in Eagan, Minnesota.
Buy / hold / sell counts